Mettler-Toledo International Inc. announced its first-quarter 2025 financial results, with GAAP diluted earnings per share (EPS) of $7.81, compared to $8.24 in the prior-year period. Adjusted EPS for the quarter was $8.19, an 8% decrease from $8.89 in the previous year, though it surpassed analyst estimates. Total reported sales declined 5% to $883.7 million, down from $925.949 million in Q1 2024, but also beat analyst expectations.
Local currency sales for the quarter decreased by 3%. Excluding the impact from delayed fourth-quarter 2023 shipments that benefited Q1 2024 results, local currency sales increased by 3%, driven by solid growth in the Laboratory business. The company noted that ongoing global trade disputes have significantly increased uncertainty in global customer demand.
For the second quarter of 2025, management anticipates local currency sales to increase approximately 0% to 1%. Adjusted EPS is forecast to be $9.45 to $9.70, representing a growth rate of down 2% to up 1%, and includes an estimated 3% headwind to Adjusted EPS growth due to higher tariff costs.
Mettler-Toledo revised its full-year 2025 outlook, now projecting local currency sales to increase approximately 1% to 2%, which includes a 1.5% headwind from the 2023 shipping delays. Adjusted EPS for the full year is forecast to be in the range of $41.25 to $42.00, representing 0% to 2% growth. This updated guidance is a reduction from the previous forecast of $42.35 to $43.00 and incorporates estimated headwinds of 4% from shipping delays and 2% from higher tariff costs. The company estimates gross incremental global tariff costs of approximately $115 million on an annualized basis, with mitigating actions expected to fully offset these costs next year.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.